Cancer Stem Cell Conference | Cancer Stem Cell Congress | Oncology Research Conference | Neuroendocrine Cancer Conference | Immunotherapy Conference | Cancer Immunology Conference | Immunotherapy Conference | Cancer Genomics Conference | Amsterdam | Netherlands | Europe | USA | Middle East

Theme: Turning Stem Cells into Cancer Treatment

Cancer Stem Cells 2022

Renowned Speakers

Liane Deligdisch
Professor of Pathology and Obstetrics-Gynecology The Mount Sinai Icahn School of Medicine, New York
USA

Karsten Ridder
MVZ Uhlenbrock & Partner. Dortmund
Germany

Nandini Manoli
Professor, Department of Pathology, JSS Medical College, a constituent of JSS AHER, Mysuru, Karnataka
India

Michael Retsky
Professor at university college London
UK

Maria Bourazani
Agios Savvas - Anticancer Hospital
Greece

Mahmoud Saad Mohamed El-Khodary
Suez Canal University, Ismailia
Egypt

Lamiss Mohamed
Tanta University,
Egypt

Suheil Simaan
Damascus University,
Syria

Cancer Stem Cells 2022

Conferenceseries Ltd, welcomes all the participants from all over the world. We are delighted to invite you all to attend the “14^thInternational Conference on Cancer Stem Cell & Oncology Research” which is going to be held on March 21-22, 2022 in Amsterdam, Netherlands. The congressional committee is gearing up for an exciting and informative event which include keynote presentations, plenary lectures, young research forum, symposia and oral talks on informative topics, poster presentations and various program for participants from all over the world. We heartily invite participants from all over the globe to take part in Cancer Stem Cells 2022, to share meaningful experience from scholars around the world.

Cancer Stem Cells 2022 welcome to all the participants in this conference which scheduled on March 21-22, 2022 in Amsterdam, Netherlands with a theme “Recent approaches and developments in Stem cell research”. This conference brings together the specialists from all the aspects to discuss about the future of oncology and cancer in today’s world to thrive and survive with a better health.

We gladly welcome all the attendees around the world for the hearing of the foremost recent innovations and inventions in the field of cancer. This conference will provide a place for the exchange of ideas and views by leading scientists, researchers and also from the academicians around the globe. There will be many outstanding keynote speakers and well known leading scientists and experts from various places of the globe to share their ideas and talk about various aspects related to the field of Cancer stem cells. Our aim is to gather peer researchers, young scientists, academicians & industrialists to meet, discuss and share the ideas related to it and the knowledge that’s still more to be revealed. We heartily encourage you to attend and contribute to one of the major events of 2022 in the field of Cancer stem cells.

Target Audiences

Session 1- Oncology R esearch

Oncology is the branch of medication that deals with the prevention, diagnosis, and treatment of cancer. Survival has been enhanced due to three primary segments including enhanced counteractive action endeavours to diminish presentation to chance elements (e.g., tobacco smoking and liquor utilization), enhanced screening of some tumours (taking into consideration prior finding), and upgrades in treatment.

Session 2- Cancer Stem Cells

Cancer stem cells are the small number of cells within a tumor that drive the tumor's growth. These cells generally make up just 1% to 3% of all cells in a tumor. Cancer research focuses on stem cells present in malignant tumors. Researchers believe current cancer treatments sometimes fail because they do not destroy the cancer stem cells. Consider cancer as a weed: the stem cells are the foundation while the remaining majority of the cells are a part of the weed above ground. If you remove only the leaves but not the basis, the weed will grow back. The identical is true for cancer: if you are doing not kill the cancer stem cells, the cancer is probably going to return.

Cancer stem cell evidence declares the presence of the a little population of disease cells with characteristic functions taking into account protection from radio-chemotherapy organized and expanded metastatic ability.

Session 3- Etiology and Prevention

“Prevention is better than cure.” – By Johann Wolfgang von Goethe.

It is extremely hard to understand why one people develop cancerous cells and another doesn’t. But some research and analysis showed that certain risk factors which may increase the chances of cancer. Some of the common risk factors can be avoided such as lifestyle and environmental factors. Most of the researches have shown that the majority of cancers are caused by poor lifestyle like unhealthy diet, smoking and obesity. Not all cancers are preventable but we can slow down the risk of cancer by applying healthy habits, such as exercise regularly, quit smoking, limited alcohol intake etc.

Session 4 -Stages of Cancer

There are four different Stages of Cancer, which include Stage 0 – when no cancer, but some abnormal cells that may give rise to cancerous cells, Stage 1 – When Cancer is located in small area, Stage 2 & 3- When Cancerous cell has spread to larger area including tissues and lymph nodes, and Stage 4 When Cancerous cell has spread to many parts of the body.

Session 5 - Cancer Diagnosis and Treatment

Cancer is the major causes of death in the world. Most of the cancer can be cured if it detect at earlier stage. There are many approaches to cancer diagnose and treatment cancer that will depend on the type of cancer and stage. Cancer diagnose approaches can be more than one. You can determine diagnosis what best is for depend on your own risk. The main aim of cancer treatment is to kill or destroy cancerous cells. The treatment options are surgery, chemotherapy or Radiation etc. Cancer treatments have many objectives, like Primary treatment, Adjuvant treatment and Palliative treatment.

Session 6- Endocrine and Neuroendocrine Cancer

The nervous system is common regulatory system in the human body. It is usually connected to the brain and the spinal cord through various nerves. Neuroendocrine cancers are type of cancer which rises in specialized cells. These types of cancer are rare but can occur anywhere in the body. Some cancerous cells grow rapidly and some grow slowly in the body. Most common neuroendocrine cancer occurs in lungs, pancreas, appendix, intestines and rectum. Neuroendocrine cancer may be occurs in thymus, thyroid gland, pituitary gland and adrenal gland. Neuroendocrine cancer can be classified by site of formation.

Session 7- Immuno-Oncology and Immunotherapy

Cancer Immunology is the branch of biology in which explore the interaction between the role of immune system or responses and progression and development of cancer. Immunotherapy or biological therapy is the treatment of cancer in which doctors boosts the natural defenses to fight cancer. There are the three classes of immunotherapy: Immune checkpoint blockade, cellular (t-cell) transfer therapy, Monoclonal antibody and vaccination. Immunotherapy causes side effects which include pain, redness and itchiness etc.

Session 8- Cancer Drug Development

Drug Development is the lengthy procedure because it has ability new drug must be identified and assessed in preclinical and clinical trials. Drug development medication can happen some different ways. If scientist identify new drug by examine numerous compounds in a laboratory procedure for effective ways, like killing or destroying cancerous cells. Cancer drug development is to target DNA or protein. Currently researchers are looking for whole new set of targets. Development of anti-cancer drug is evolving a step towards the invention of novel therapeutics.

Current concept of understanding the kind of cancer invent to conceptual drug design, in which new substance is developed to target a specific disease procedure. At a time, factual medication are found to be having an effectual effect against a various type of cancerous cells. New discovery lead to alteration in designs how medication reach cancerous cells present among the body, thus leading to the capacity to develop a substance. At starting procedure is referred to target and lead identification, validation, and optimization.

Session 9- Artificial Intelligence and Oncology

Artificial Intelligence means human like intelligence performed by a computer, robot, or other machine. There is various kind of application and uses of artificial intelligence in the field of medical oncology and basic cancer research like in diagnosis, screening, imaging, drug discovering, clinical trials, pain management and treatments etc. Recently technological uses and application of artificial intelligence in oncology are endless.

Artificial Intelligence in Oncology covers a huge range of application in cancer management. A new artificial intelligence (AI) system created that not only matches tumors to the best drug combinations, but does so in a way that makes sense to humans. Artificial Intelligence is expecting the best approach to cancer treatment.

Session 10- Cancer Genomics

Genomics is the study of genomes. It is a field of biology which involve the structure, mapping, evolution, and editing of genomes. The genome is the whole set of DNA, which include its genes. The study of cancerous genomes has disclosed the abnormalities in DNA or genes that leads to development and growth in various ways. The invention of cancerous causing genetic and epigenetics alteration in tumor has enabled the development of therapies which target there alteration as well as treatment and diagnosis test which identifies patients who may effective from these therapies.

Session 11- Cancer Syndromes

Cancer syndromes is the genetic disorder in which hereditary genetic alteration in single or multiple genes predispose the affected of single to the development of tumor. Cancerous syndromes display a high risk of tumor. Hereditary genetic alteration play important role in approximately 5% to 10% of all tumors. These epigenetic alterations happen at different levels, which involve decreased mass degrees of the center histones, adjusted examples of histones post-translational changes and DNA methylation, supplanting of authoritative histone along with histone changes and modification non-coding RNA articulation, in the process of organismal maturing and replicative senescence.

Session 12- Computational Data mining in Cancer

Computational data mining has an ability to understand the difficulties of cancerous-related data has been caused by the application of computer and data sciences, which involve data mining, analytics, machine learning and benefits in imaging technology and probe creation. Computational modeling and simulation are orderly and cheaper tools which able to identify important temporal patterns, characteristic distinct molecular character of tumor states and other related aspects, which include tumor identification and heterogeneity, progression and metastasis, and medication resistance.

Session 13- Tissue regeneration and Oncology

Tissue Regenerative medication is the model of renewal and restoration of damaged or destroyed tissues. As the segment for organ development and tissue restoration, stem cells have different and vast-ranging ability, thus describing their ability application and uses to tissue regenerative medication. The identification that compatible model of molecular procedure drive organ development and after birth tissue regeneration has remarkable implications for a different of cytological diseases beyond renewal biology. The examination analysis that organ-specific stem cells acquire all of the changed cells within a given tissue has led to the acceptance of a stem cell inheritance pattern for tissue development, maintenance, and repair. Extending the tissue stem cell hierarchical model to tissue tumorigenesis may transform the pattern in which we form a concept of cancer medication. A basic understanding of stem cell biology is dominant to stay knowledgeable of this mixing technology and the go along with discovery in this with field the ability in clinical application and uses.

Session 14- Vaccines and Biomarkers

Vaccines are medication which helps our body to fight against disease. Vaccine can train are immune system to search and damage or destroy harmful micro-organisms, germs, and cells. There are various kind of vaccines that we receive throughout our life to prevent common sickness or illness. There are also vaccines available for tumor or cancer. There are vaccines which prevent tumor and treatment of cancer. There are vaccinations which prevent people from getting particular cancers caused by viruses. This type of vaccine will only work if a person gets the vaccination before they are infected with the virus.

Research into the molecular biology of hepato-carcinogenesis has known some biomarkers, which could offer additional evidence in order to better comprehend the biology of HCC. An abundance of biomarkers have been shown to have possible analytical implication and a wide variety of molecular markers have been verified to be excellent diagnostic tools for HCC yet it is hard to expose HCC with a single biomarker. Then, marks of a mix of biomarkers might be more imperative for the finding, arranging and visualization of HCC.

Session 15- Coronavirus and Cancer Treatment

Coronaviruses are the large group of viruses. SARS-CoV- 2 is a novel which caused a pandemic of disease named COVID-19, anyone who expose to infection and developing COVID-19. Recently, it not known that history of cancer patient increases the risk for some sickness or illness from COVID-19. Cancer and its treatment can weaken immune system and reduce your potential to against fight infections. The immune system protects our body against illness and infection caused by viruses like COVID-19.

Session 16- Cancer Nanotechnology

Cancer nanotechnology is the application and uses of Nano meter product towards the identification, diagnosis, and treatment of cancer. The unique properties of nanomaterial and the connection with cells in and around the tumor micro-environment are enabling new aspects in cancer biology and therapy. The huge of applications of nanotechnology towards cancer continues to expand with exciting new developments in combination treatments, cancer immunotherapy, molecular detection, and imaging.

Scientist will provide a unique forum where scientists at every stage of their career can share unpublished, cancer discovery made possible by the use of nano particles or nano-materials. This meeting will particularly focus on two ends of the spectrum in cancer research: deepening our fundamental understanding of the interactions of nano -materials with tumors and the laboratory favourable environment, and translation of cancer nanotechnology out of the lab and into the clinic. The event will bring together a lively group of exceptional scientists in order to

(i) share cutting-edge discovery in cancer nanotechnology by expertise representing the wide range of biological sciences, engineering, and medication;

(ii) Discussion, presenting of ideas, and promote collaborations,

(iii) Enhance growth of fresh researcher during promoting variety.

Session 17- Cancer Genetics

Genetics is the field of biology that looks at how character passed down from parents to their children through genes. Alteration in genes called mutation, which play an important role in the building blocks of tumor. Alteration in gene can cause a cell to make proteins that affect cell growth and division into new cells. This type of alteration in genes leads to out of control cells, which can cause cancer.

Session 18– Cancer Misconception and Myth

It’s important to range the awareness about cancer and crucial to stay away from myth and misconceptions. The internet full of myths and misconceptions related to cancer which stop patient from getting diagnosed on time and availing treatments.

This event tries to present cancer myths and misconceptions vs facts to make you aware of this disease.

Session 19 – Current Application and Future of cancer

The main agenda is to focus on new translational advances in the treatment of cancer as well as provide updates of predictable therapies for the number of the most common tumor types. The major emphasis will be clinical features of cancer treatment in this century with debate of important scientific advances underlying the novel methods still in preclinical development.

Session 20- Cancer Nursing

Cancer patient Nurse is a professional who take cares of Cancer patients. Cancer patient nursing care could be defined as the expert care and completing the needs of patients during the time of their disease, while may involve some screening methods and preventive measures that should be taken care of patient care, fatigue, infection etc.

Session 21- AIDS-Related Cancer

Acquired immune deficiency syndrome (AIDS) is a disease of the immune system caused by human immunodeficiency virus (HIV). HIV is transmitted from one person to another typically in blood and physical secretions, which includes semen.

People with HIV/AIDS are most likely to develop the following cancers:

The link between HIV/AIDS and some cancers is not entirely understood, but it probably depends on the weakening of the immune system. Most types of cancer begin when healthy cells change and develop out of control, forming a lump called a tumour. A tumor can be cancerous or benign. A cancerous tumor is malignant, which means it can develop and spread to other areas of the body. A benign tumor means the tumor can grow but will not spread.

Session 22- Pediatric Oncology

Pediatric Oncology is rare, and more readily diagnosed and treated than ever.

Paediatric oncology is research and cancer treatment for children and young adults. Pediatric oncologists study and train in both pediatrics and oncology. The types of cancers that develop in children are often different from cancers that develop in adults.

Pediatric Cancer is not a single disease type, but an large group of diseases that include blood cancers (leukemia and lymphoma), brain tumors and other solid tumors of the organs, bones or soft tissues.

Pediatric oncology treatment may include

Session 23- Molecular Oncology

Molecular Oncology is a multidisciplinary basic science programme with expertise in cancer stem cells, DNA damage repair and genomic instability, tumor-host interactions, and other fundamental aspects of cancer biology.

Discover the regulatory mechanisms that generate cellular heterogeneity and therapeutic resistance in cancer stem cells (CSCs).
Figure out how genetic instability affects tumour heterogeneity, progression, and treatment resistance.
Examine the relationships between cells in tumour formation, dormancy, metastasis, and therapeutic resistance, with a focus on immunological and microbiome changes

Session 24- Radiation Oncology

Radiation oncology is a medical specialty that is an important component of a multidisciplinary cancer treatment approach. It works by delivering high-energy x-rays (photons) through a linear accelerator. These painless and undetectable therapeutic x-rays are used to treat a variety of malignancies.

Recent technology has combined the use of 3-D imaging technology, computerized treatment planning and high-energy x-ray machines to make more precise treatment possible. Professionals involved in radiation therapy treatment include:

Session 25- Neuro-Oncology

Neuro-oncology is the study of cancers within the brain and medulla spinalis Cancers within the nervous system are usually serious and critical. In some cases, survival is extended using chemotherapy and radiation therapy.

Session 26- Precision Medicine For Cancer

Precision medicine, also called personalized medicine, is an approach to treating cancer that is customized to each individual patient. A major factor in precision medicine is an individual’s DNA molecules, gene sequences and unique genetic history. Cancer is the result of a genetic malfunction that causes cells to develop out of control, creating tumors. Understanding a person’s complete set of DNA, also called the genome, is the first step in using precision medicine to guide treatment. The more researchers know about genetic sequencing and DNA analysis of cancer tumors, the more specialized treatment options may be available, especially if a person’s cancer stops responding to standard treatment.

Session 27- Cancer Stem Cells & the Tumor Microenvironment

A growing body of evidence indicates that the tumor microenvironment contributes to tumor growth and viability, while significant advances are being made within the understanding of cancer stem cells and tumor initiating cells. The session will discuss on breaking developments on novel tumor-killing strategies and preclinical and clinical projects which are exploiting cancer stem cells, the inflammatory component of tumors, and therefore the tumor microenvironment for therapeutic intervention.

Mechanisms of Tumor Promotion by Inflammatory Cells
Targeting the Inflammatory Component of Tumors
Compounds Targeting the Tumor Microenvironment
Compounds Targeting Inflammation and Cancer
Molecules Targeting Cancer Stem Cells
Targeting Cancer Stemness Pathways

Session 28- Pancreatic Cancer Stem Cells

Pancreatic cancer stem cells have some similarities to cancer stem cells found in other kinds of cancer; however, there also appear to be some significant differences. This is often why it's important to review the function of those cells within the specific cancer during which these cells arise to best understand their function. No matter the organ within which they're found, cancer stem cells appear to be answerable for the propagation of cancer and for its spread to other organs within the body. But they will do that in several ways.

Session 29- Breast Cancer Stem Cells

Breast cancer stem cells - the primary to be identified in an exceedingly solid tumour - were discovered in 2003 by scientists at the U-M Comprehensive Cancer Centre. U-M scientists found that just some cancer stem cells are chargeable for the expansion and spread of carcinoma. Unless the cancer stem cells are destroyed, the tumour is probably going to come back and spread malignant cells to other parts of the body, a process called metastasis.

Session 30- Prostate Cancer Stem Cells

Prostate cancer is now a standard disease in men over 50 years old. Medical therapies for glandular carcinoma are supported discoveries from the mid-twentieth century, and within the future are rarely curative. Most treatments are directed towards an androgen receptor-expressing, highly proliferative target cell, which does indeed form the overwhelming majority of cells during a prostate tumour. However, by invoking the existence of a cancer vegetative cell which, like normal epithelial stem cells within the prostate, doesn't express androgen receptor and is comparatively quiescent, the observed resistance to most medical therapies are often explained. The phenotype of the glandular cancer stem cells is that of a basal cell and cultures derived from cancers, but not benign tissues, express a spread of prostate cancer-associated RNAs.

Session 31- Gastric Cancer Stem Cells

Gastric cancer could be a significant global ill health. It's the fifth most typical cancer and third leading reason for cancer-related death worldwide. Despite advances in treatment, overall prognosis remains poor, because of tumour relapse and metastasis. There's an urgent need for novel therapeutic approaches to boost clinical outcomes in gastric cancer. The cancer somatic cell (CSC) model has been proposed to elucidate the high rate of relapse and subsequent resistance of cancer to current systemic treatments. CSCs are identified in many solid malignancies, including gastric cancer, and have significant clinical implications, as targeting the CSC population could also be essential in preventing the recurrence and spread of a tumour.

Session 32- Ovarian Cancer Stem Cells

The cancer Stem cell (CSC) model proposes that tumor development and progression are fuelled and sustained by undifferentiated cancer cells, endowed with self-renewal and tumor-initiating capacity. Ovarian carcinoma, supported its biological features and clinical evolution, appears as a prototypical example of CSC-driven disease. Indeed, ovarian cancer stem cells (OCSC) would account not just for the first tumor growth, the peritoneal spread and also the relapse, but also for the event of chemo resistance, thus having profound implication for the treatment of this deadly disease.

Session 33- Lung Cancer Stem Cells

Lung cancer remains a significant explanation for cancer-related lethality due to high incidence and recurrence in spite of great advances in staging and therapies. Recent data indicates that stem cells situated throughout the airways may initiate cancer formation. These putative stem cells maintain protumorigenic characteristics including high proliferative capacity, multipotent differentiation, drug resistance and long lifespan relative to other cells. Stem cell signalling and differentiation pathways are maintained within distinct cancer types, and destabilization of this machinery may participate in maintenance of cancer stem cells. Characterization of carcinoma stem cells is a section of active research and is critical for developing novel therapies. This review summarizes the present knowledge on Stem cell signalling pathways and cell markers wont to identify the carcinoma stem cells.

Blood Cancer is a type of cancer that starts in the bone marrow, where blood is produced. There are many symptoms which include fever, chills, fatigue, weakness, weight loss, bone and joint pain, anemia. Treatments include chemotherapy, radiation, stem cell transplant, surgery, immunotherapy.

Abbott Laboratories
AbbVie
ACS Biomarker B.V.
Actavis USA
Affymetrix, Inc
Alizé Pharma
Amgen USA
Ariad Pharmaceuticals, Inc.
AstraZeneca
Benco Dental
Biogen Idec USA
BioHorizons
BioM AG Munich
Biomarker Pharmaceuticals, Inc.
Boehringer Ingelheim
Bristol-Myers Squibb USA
Carestream Dental
Celgene USA
Celldex Therapeutics
Centrix Dental
Clovis Oncology
Delta Dental
Dendreon
DenMat
DentistryIQ
DENTRIX Ascend
DENTSPLY Implants
Eli Lilly & Co USA
Gilead Sciences
GlaxoSmithKline
Glidewell Laboratories
Henry Schein
Integrated Dental Systems
Johnson & Johnson
Johnson & Johnson US
Kerr Dental Company | Kerr Dental
Lupin Ltd.
Marotta Dental Studio
Medivation
Merck
Merck & Co.
Merck USA
Novartis
Omnia LLC
Oncogenex
OralCDx
OralID
Panaeca Biotech Ltd.
PATTERSON Dental
Pfizer
Pfizer USA
Pharmacyclics
Pharmascience Inc.
Piramal Healthcare
PLANMECA -Digital Perfection
Prostagene
Radient Pharmaceuticals
Ranbaxy
RaySearch Laboratories
Roche
Roche Diagnostics Corporation
Sanofi
Sanofi FRA
Spectrum Pharmaceuticals, Inc. - Acute lymphoblastic leukemia
Sun pharma
Takeda
Takeda
US Biomarkers
Zimmer Dental

The international most cancers stem cells marketplace length became worth USD 679.five million in 2016. The marketplace is anticipated to enlarge at a CAGR of 9.98% at some point of the forecast period. Currently, oncology therapeutics has entered a brand new generation with traditional treatment plans inclusive of radiotherapy, chemotherapy, & surgical procedures on one facet and stem mobileular treatment plans on any other facet.

Over the beyond few years, stem cells are being efficaciously applied in immuno-reconstitution and for replenishment of blood after tumor improvement or after tumor treatment. Furthermore, those cells have received substantial interest amongst healthcare entities for his or her employment as equipment for the shipping of anti-cancer causing agents in addition to for tissue regeneration. A big range of entities have mentioned fine effects of the use of this mode of tumor treatment.

While this therapy is receiving huge success in clinical oncology, a substantial number of published studies have mentioned cancer as “Cancer Stem Cell (CSC) disorder”. Due to introduction of this novel concept, an enormous potential for anti-CSCs therapeutics has been created.

This approach enables comprehensive investigation of essential as well as poorly understood clinical events in tumor initiation, propagation, relapse, and metastasis. This is considered as one of the major factors responsible for increasing interest in the cancer stem cell model.

There is accumulating evidence that sheds light on the existence of cancer stem cells and their role in conferring drug resistance. This further provides the possibility for generating novel targets to overcome therapeutic resistance by controlling regulation of these cells. Hence, CSCs, as potential therapeutic targets, enable therapeutic development that effectively combat tumor progression.

However, regulatory challenges pertaining to approval and usage of stem cell therapies are anticipated to inhibit growth of the market. In addition, certain manufacturing and pharmacological issues associated with this cell therapy development are estimated to slow down the progress of the market during the forecast period.

Acute myeloid leukaemia (AML): Leukaemia Foundation
Alzheimer's Association
American Association for Cancer Research
American Association Oral and Maxillofacial Surgery
American Brain Tumor Association
American Brest Cancer Foundation,
American Cancer Society
American Cancer Society
American Cancer Society
American Childhood Cancer Organisation
American Childhood Cancer Organization
American Society for Blood & Marrow Transplantation(ASBMT)
American Society for Colposcopy and Cervical Pathology ,
American Society for Colposcopy and Cervical Pathology,
American Society of Clinical Oncology
American Society of Haematology
American Society of Paediatric Hematology/Oncology
APHCON Home: ASIA-PACIFIC HEMATOLOGY CONSORTI
Asian and Pacific Federation of Organization for Cancer Research and Control,
Association for Molecular Pathology
Australia: Leukaemia Foundation
Australian & New Zealand Children’s Hematology/Oncology Group
Australian Prostate Cancer Research Centre
BC Cancer Foundation
Biomarkers profile corporation
Biomarkers society
Bone Marrow Transplants - Neutropenia Support Association Inc.
British Association of Urological Surgeons (BAUS)
Canadian Cancer Society
Cancer Association of Botswana
Cancer Research Institute
Cancer Research Institute, USA
Cancer Research Society
Cancer Research UK
Cancer Society of America
Child Cancer Foundation
Childhood Cancer Research Group
Childhood Leukemia Foundation
Children with Cancer UK
Children’s Cancer and Leukaemia Group
Children's Leukemia Research Association, Inc
Children's Leukemia Research Association, Inc.
China: Shanghai Roots & Shoots: CML Home of Hope
Chronic Myelogenous Leukaemia Society of Canada
CML Patient Organisations
Colon Cancer Canada
Colorectal Cancer Association of Canada - CCAC
Council of European Dentists
Damon Runyon Cancer Research Foundation
Emirates Society of Hematology
Emirates Society of Hematology
European Cancer Organisation
European Cervical Cancer Association ,
European Head and Neck cancer Awareness
European Hematology Association
European society of molecular imaging
Foundation for Head and Neck Oncology
Gastrointestinal Society
German Cancer Research Centre
German Society for Oncological Pharmacy
Gromada Head & Neck Cancer Foundation
Hairy cell leukaemia (HCL) | Lymphoma Association
Head and Neck Cancer Alliance
IAOO: International Academy of Oral Oncology
Indonesia: Indonesian CML & GIST Community (ELGEKA Indonesia)
International Academy of Oral Oncology
International Agency for Research on Cancer
International Cancer Genome Consortium
International Federation for Cervical Pathology and Colposcopy,
International Melanoma Working Group
International Myeloma Foundation
International society for oncology and biomarkers
Irish Cancer Society
Israel Cancer Research Fund
Korean Breast Cancer society,
Latvia: Association of Support for Leukemia Patients (Leikemijas slimnieku atbalsta biedriba)
Leukemia & Lymphoma Foundation
Leukemia & Lymphoma Society
Lymphoma Association
Lymphoma Coalition
Lymphoma Foundation Canada
Lymphoma Research Foundation of America
Medical Centre Cologne
Mouth Cancer Foundation
Multiple Myeloma Research Foundation
National and International Cancer Organisations
National Breast Cancer Foundation
National Cancer Institute
National Cancer Institute
National Cancer Institute at the National Institutes of Health
National Cancer Institute Egypt
National Pancreatic Cancer Canada Foundation
Ontario - Canadian Cancer Society
Oral Cancer Foundation- OCF
Peruvian Cancer Foundation
Prostate Cancer Canada
Prostate Cancer Foundation
Prostate Cancer Foundation of Australia
Prostate Cancer UK
Sacndinavian Society for Head and Neck Oncology
Singapore Cancer Society
Society of nuclear medicine and molecular imaging
South African Head and Neck Oncology- SAHNOS
South African Oncology Consortium- SAOC
Testicular Cancer Society
The ALS Association
The Biomarkers consortium
The British Associationfor Cancer Research
The Canadian Cancer Society
The Cancer Association of South Africa
The Cancer Association of South Africa- CANSA
The European Cancer Organization
The Ewings Cancer Foundation of Canada
The Global Oral Cancer Forum
The International Society Of Oncology and Biomarkers
The National Children's Cancer Society - NCCS
The South African Society of Clinical and Radiation Oncologists- SASCRO
The Swedish Cancer Society
The UICC Asia-Pacific Cancer Society Training Grants,
The V Foundation for Cancer Research
Turkey: The Leukemia, Lymphoma, Myeloma Patients Research and Education Society (LLMBIR)
UK Oncology Nursing Society
Union for International Cancer Control
United Kingdom Association of Cancer Registries
Urological Association of Asia and Iranian
World molecular imaging society

Cancer Stem Cells 2020

The success of the Global Cancer 2018 conference has given us the prospect to bring the gathering one more time. Conference Series llc LTD hosted the “12^th International Conference on Cancer Stem Cell and Oncology Research” during June 15-16, 2020 | Webinar

The gathering was centered on finding about Oncology with the subject “Innovation in Cancer Research and Projections of Novel Therapeutic Approaches”. The meeting for the most part coordinates towards tending to fundamental issues like Prevention, Diagnosis, and Treatment ailments of the Organ-related Cancers and its imaginative systems. Cancer Stem Cells 2020 is a champion among the most reviving Cancer Conferences dealt with by Conference Series llc LTD. This Oncology Meeting was discussed on systems and approaches related to organization, quality change of Cancer and to research the new contemplations and thoughts on overall scale and the focuses consolidate lung tumor, bosom tumors, bone malignancy, colon-rectum illness, prostate tumor, thyroid tumor.

The conference was embarked with an opening ceremony followed by Keynote sessions and followed by series of lectures delivered by both Honorable Guests and members of the Keynote forum. The adepts who announced the theme with their flawless talk were:

Stefan Gluck - Celgene Corporation, USA
Chang Gang, Sun Yat-Sen University, China
Emmanuelle Charafe-Jauffret, University of Mediterranee, France
Keith Potent, Monash University, Australia
Xiaoxiao Jiang, Fudan University School of Pharmacy, China
Shahana Pervin, National Institute of Cancer Research & Hospital, Bangladesh
Polly Leilei Chen, Cancer Science Institute of Singapore, Singapore
Lu-Hai Wang, China Medical University, Taiwan
Kshama Pansare, Tata Memorial Centre Advanced Centre for Treatment Research & Education in Cancer, India
Samira B A Sesay, Zhengzhou Medical University, China
Danmaigoro Abubakar, Universiti Putra Malaysia, Malaysia
Suganya Sakthivel, Tzu Chi University, Taiwan

Conference Series llc LTD offers its passionate appreciation to Organizing Committee Members, adept of field, distinctive outside masters, association specialists and is obliged to different well known characters who joined with Conference Series llc LTD and reinforced the conference in each edge, without which the meeting would not have been possible.

Your response is our motivation; remembering this proverb and being seen the triumph of Cancer Stem Cells 2020, Conference Series llc LTD might want to report the initiation of the "Cancer Stem Cell and Oncology Research" to be held in June 15-16, 2020 | Webinar. We welcome all the eminent researchers, undergraduates, PhD scholars and delegate members to take part in this upcoming meeting to witness important logical examinations and add to the future developments in the field of Oncology and Tumor Research.

For More details: https://cancerstemcells.insightconferences.com/2020

Let us meet again @ Cancer Stem Cells 2022

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	March 21-22, 2022
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed
Poster Opportunity Closed	Click Here to View